476
Views
25
CrossRef citations to date
0
Altmetric
ORIGINAL INVESTIGATION

Major depression and electrovestibulography

, , , , , & show all
Pages 334-350 | Received 12 Aug 2014, Accepted 26 Jan 2015, Published online: 27 Mar 2015

References

  • Alcaro A, Panksepp J, Witczak J, Hayes DJ, Northoff G. 2010. Is subcortical–cortical midline activity in depression mediated by glutamate and GABA? A cross-species translational approach. Neurosci Biobehav Rev 34:592–605.
  • Anderson AD, Troyanovskaya M, Wackym PA. 1997. Differential expression of alpha2-7, alpha9-10 and beta2-4 nicotinic acetylcholine receptor subunit mRNA in the vestibular end organs and Scarpa's ganglia of the rat. Brain Res 778: 409–413.
  • Austin MP, Mitchell P. 1996. Melancholia as a neurological disorder. In: Parker G, Hadzi-Pavloic D, editors. Melancholia: A disorderof movement and mood. New York, NY: Cambridge University Press. p. 223–236.
  • Balaban CD, Jacob RG, Furman JM. 2011. Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications. Expert Rev Neurother 11(3):379–394.
  • Bernard R, Kerman IA, Thompson RC, Jones EG, Bunney WE, Barchas JD, et al. 2011. Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry 16(6): 634–646.
  • Brown DJ, Patuzzi RB. 2010. Evidence that the compound action potential (CAP) from the auditory nerve is a stationary potential generated across dura mater. Hearing Res 267:12–26.
  • Cannon DM, Klaver JM, Peck SA, Rallis-Voak D, Erickson K, Drevets WC. 2009. Dopamine Type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112 Neuropsychopharmacology 34:1277–1287.
  • Cortes C, Calindo F, Galicia S, Cebada J, Flores A. 2013. Excitatory actions of GABA in developing chick vestibular afferents: effects on resting electrical activity. Synapse 67(7): 374–381.
  • Davidson RJ. 1993. Cerebral asymmetry and emotion: methodological conundrums. Cogn Emotion 7:115–138.
  • Dieterich M, Bense S, Lutz S, Drzezga A, Stephan T, Bartenstein P, et al. 2003. Dominance for vestibular cortical funcion in the non-dominat hemishpere. Cereb Cortex 13(9): 994–1007.
  • Drescher MJ, Cho WJ, Folbe AJ, Selvakumar D, Kewson DT, Abu-Hamdan MD, et al. 2010. An adenylyl cyclase signaling pathway predicts direct dopinergic input to vestibular hair cells. Neuroscience 171(4):1054–1074.
  • Drevets WC, Furey ML. 2010. Replication of Scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial. Biol Psychiatr 67(5): 432–438.
  • Ennis M, Shipley MT, Aston-Jones G, Williams JT. 1998. Afferent control of nucleus locus ceruleus: differential regulation by “shell” and “core” inputs. Adv Pharmacol 42:767–771.
  • Guo C, Wang Y, Zhou T, Yu H, Zhang W-J, Kong W-J. 2012. M2 muscarinic ACh receptors sensitive BK channels mediate cholinergic inhibition of type II hair cells. Hearing Res 285: 13–19.
  • Heibert D. 2010. Computer models of the vestibular head tilt response, and their relationship to EVestG and Meniere's disease [Doctor of Philosophy thesis]. Monash University.
  • Highet N. 2008. Depression monitor survey. Melbourne: Beyondblue.
  • Johnston-Wilson NL, Sims CD, Hofmann JP, Anderson L, Shore AD, Torrey EF, et al. 2000. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. Mol Psychiatry 5: 142–149.
  • Kerman IA, Bernard R, Bunney WE, Jones EG, Schatzberg AF, Myers RM, et al. 2012. Evidence for transcriptional factor dysregulation in the dorsal raphe nucleus of patients with major depressive disorder. Front Neurosci 6:135.
  • Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, et al. 1997. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci 17(21):8451–8458.
  • Li C, Zhang Y, Guan Z, Shum DKY, Chan Y. 2005. Vestibular afferent innervation in the vestibular efferent nucleus of rats. Neurosci Lett 385:36–40.
  • Lithgow BJ. 2012. A methodology for detecting field potentials from the external ear canal: NEER and EVestG. Ann BME 40(8):1835–1850.
  • Luscher BE, Shen Q, Sahir N. 2011. The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 16(4):383–406.
  • Marlinsky V. 1995. The effect of somatosensory stimulation on second-order and efferent vestibular neurons in the decerebrate decerebellate guina-pig. Neuroscience 69:661–669.
  • McGeer PL, McGeer EG, Mizukawa K, Tago H, Peng JH. 1987. Distribution of cholinergic neurons in human brain. In: Dun NJ, Perlman RL, editors. Neurobiology of acetylcholine. A Symposium in Honor of A.G. Karczmar. New York: Plenum Press. p. 3–16.
  • McLachlan GJ. 1992. Discriminant analysis and statistical pattern recognition. New York: John Wiley & Sons.
  • Meredith FL, Benke TA, Rennie KJ. 2012. Hyperpolarization-activated current (Ih) in vestibular calyx terminals: characterization and role in shaping postsynaptic events. J Assoc Res Otolaryngol 13:745–758.
  • Montgomery SA, Asberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry: J Ment Sci 134:382–389.
  • Murray CJ, Lopez AD. 2013. Measuring the global burden of disease. New Engl J Med 369:448–457.
  • Pérez C, Limón A, Vega R, Soto E. 2009. The muscarinic inhibition of the potassium M-current modulates the actionpotential discharge in the vestibular primary-afferent neurons of the rat. Neuroscience 158:1662–1674.
  • Philip NS, Carpenter LS. 2012. The nicotinic acetylcholine receptor as a target for antidepressant drug development. Sci World J 2012(Article ID 104105):1–7.
  • Price JL, Drevets WC. 2010. Neurocircuitry of mood disorders. Neuropsychopharmacology 35:192–216.
  • Rio C, Dikkes P, Liberman MC, Corfas G. 2002. Glial fibrillary acidic protein expression and promoter activity in the inner ear of developing and adult mice. J Comp Neurol 442:156–162.
  • Sara SJ. 2009. The locus coeruleus and noradrenergic modulation of cognition Nat Rev Neurosci 10:211–223.
  • Saricicek A, Esterlis I, Maloney KH, Mineur YS, Ruf BM, Muralidheran A, et al. 2012. Persistent b2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder. Am J Psychiatry 169:851–859.
  • Semba K, Reiner PB, McGeer EG, Fibiger HC. 1989. Brainstem projecting neurons in the rat basal forebrain: neurochemical, topographical, and physiological distinctions from cortically projecting cholinergic neurons. Brain Res Bull. 22:501–509.
  • Soto E, Vega R. 2010. Neuropharmacology of vestibular system disorders. Curr Neuropharmacol 8:26–40.
  • Soza Ried AM, Aviles M. 2007. Asymmetries of vestibular dysfunction in major depression. Neuroscience 144(1): 128–134.
  • Wackym PA, Chen T, Ishyama A, Pettis RM, Lopez IA, Hoffman L. 1996. Muscarinic acetylcholine receptor subtype in mRNA's in the human and rat vestibular periphery. Cell Biol Int 20(3):187–192.
  • Wang J, Chi F, Xin Y, Regner MF. 2013. The distribution of vestibular efferent neurons receiving innervation of secondary vestibular afferent nerves in rats. Laryngoscope 123(5): 1266–1271.
  • Wang JC, Hinrichs AL, Stock H, Budde J, Allen R, Bertelsen S, et al. 2004. Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome. Hum Mol Gen 13(17): 1903–1911.
  • Yadav R, Gupta SC, Hillman BG, Bhatt JM, Stairs DJ, Dravid SM. 2012. Deletion of glutamate delta-1 receptor in mouse leads to aberant emotional and social behaviours. PLoS ONE 7(3):e32969.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.